L. Patrick Gage, Director at TETRAPHASE PHARMACEUTICALS INC (TTPH), bought 3,880 shares at $6.45 ($25K) on 2017-11-29, disclosed to the SEC on 2017-12-04.
Open-market purchase of $25k TTPH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| CYTK | SELL | 2021-03-12 | $439K | — | Filing → |
| CYTK | SELL | 2020-12-15 | $162K | — | Filing → |
| CYTK | SELL | 2020-03-20 | $119K | — | Filing → |